154 related articles for article (PubMed ID: 37831167)
1. Interobserver agreement and prognostic value of image-based scoring systems in patients with primary sclerosing cholangitis.
Grave EC; Loehfelm T; Corwin MT; Zepeda J; Bath HK; Dhaliwal S; Yazdanfar M; Bowlus CL
Abdom Radiol (NY); 2024 Jan; 49(1):60-68. PubMed ID: 37831167
[TBL] [Abstract][Full Text] [Related]
2. Simple Magnetic Resonance Scores Associate With Outcomes of Patients With Primary Sclerosing Cholangitis.
Lemoinne S; Cazzagon N; El Mouhadi S; Trivedi PJ; Dohan A; Kemgang A; Ben Belkacem K; Housset C; Chretien Y; Corpechot C; Hirschfield G; Floreani A; Motta R; Gallix B; Barkun A; Barkun J; Chazouillères O; Arrivé L
Clin Gastroenterol Hepatol; 2019 Dec; 17(13):2785-2792.e3. PubMed ID: 30880273
[TBL] [Abstract][Full Text] [Related]
3. Assessment of prognostic value and interreader agreement of ANALI scores in patients with primary sclerosing cholangitis.
Grigoriadis A; Ringe KI; Andersson M; Kartalis N; Bergquist A
Eur J Radiol; 2021 Sep; 142():109884. PubMed ID: 34380098
[TBL] [Abstract][Full Text] [Related]
4. Disease severity prognostication in primary sclerosing cholangitis: a validation of the Anali scores and comparison with the potential functional stricture.
Poetter-Lang S; Ba-Ssalamah A; Messner A; Bastati N; Ambros R; Kristic A; Kittinger J; Pochepnia S; Ba-Ssalamah SA; Hodge JC; Halilbasic E; Venkatesh SK; Kartalis N; Ringe K; Arrivé L; Trauner M
Eur Radiol; 2024 Jun; ():. PubMed ID: 38869640
[TBL] [Abstract][Full Text] [Related]
5. The Complementary Value of Magnetic Resonance Imaging and Vibration-Controlled Transient Elastography for Risk Stratification in Primary Sclerosing Cholangitis.
Cazzagon N; Lemoinne S; El Mouhadi S; Trivedi PJ; Gaouar F; Kemgang A; Ben Belkacem K; Floreani A; Hirschfield G; Chretien Y; Housset C; Motta R; Russo FP; Chazouillères O; Arrivé L; Corpechot C
Am J Gastroenterol; 2019 Dec; 114(12):1878-1885. PubMed ID: 31738286
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of quantitative MRCP (MRCP+) for risk stratification of primary sclerosing cholangitis: comparison with morphological MRCP, MR elastography, and biochemical risk scores.
Ismail MF; Hirschfield GM; Hansen B; Tafur M; Elbanna KY; Goldfinger MH; Ridgway GR; Jhaveri KS
Eur Radiol; 2022 Jan; 32(1):67-77. PubMed ID: 34231037
[TBL] [Abstract][Full Text] [Related]
7. Prognostic role of magnetic resonance imaging of the abdomen with intravenous contrast and magnetic resonance cholangiopancreatography in primary sclerosing cholangitis.
Grove RL; Vespa F; Aineseder M; Villamil A; Spina JC
Radiol Bras; 2023; 56(6):301-307. PubMed ID: 38504819
[TBL] [Abstract][Full Text] [Related]
8. Quantitative magnetic resonance cholangiopancreatography metrics are associated with disease severity and outcomes in people with primary sclerosing cholangitis.
Cazzagon N; El Mouhadi S; Vanderbecq Q; Ferreira C; Finnegan S; Lemoinne S; Corpechot C; Chazouillères O; Arrivé L
JHEP Rep; 2022 Nov; 4(11):100577. PubMed ID: 36277957
[TBL] [Abstract][Full Text] [Related]
9. A Quantitative Magnetic Resonance Cholangiopancreatography Metric of Intrahepatic Biliary Dilatation Severity Detects High-Risk Primary Sclerosing Cholangitis.
Selvaraj EA; Ba-Ssalamah A; Poetter-Lang S; Ridgway GR; Brady JM; Collier J; Culver EL; Bailey A; Pavlides M
Hepatol Commun; 2022 Apr; 6(4):795-808. PubMed ID: 34802195
[TBL] [Abstract][Full Text] [Related]
10. Development of a prognostic MRCP-score (DiStrict) for individuals with large-duct primary sclerosing cholangitis.
Grigoriadis A; Imeen Ringe K; Bengtsson J; Baubeta E; Forsman C; Korsavidou-Hult N; Rorsman F; Nilsson E; Kartalis N; Bergquist A
JHEP Rep; 2022 Dec; 4(12):100595. PubMed ID: 36444388
[TBL] [Abstract][Full Text] [Related]
11. A quantitative MRCP-derived score for medium-term outcome prediction in primary sclerosing cholangitis.
Cristoferi L; Porta M; Bernasconi DP; Leonardi F; Gerussi A; Mulinacci G; Palermo A; Gallo C; Scaravaglio M; Stucchi E; Maino C; Ippolito D; D'Amato D; Ferreira C; Nardi A; Banerjee R; Valsecchi MG; Antolini L; Corso R; Sironi S; Fagiuoli S; Invernizzi P; Carbone M
Dig Liver Dis; 2023 Mar; 55(3):373-380. PubMed ID: 36357293
[TBL] [Abstract][Full Text] [Related]
12. The role of magnetic resonance imaging and endoscopic retrograde cholangiography in the evaluation of disease activity and severity in primary sclerosing cholangitis.
Tenca A; Mustonen H; Lind K; Lantto E; Kolho KL; Boyd S; Arola J; Jokelainen K; Färkkilä M
Liver Int; 2018 Dec; 38(12):2329-2339. PubMed ID: 29901259
[TBL] [Abstract][Full Text] [Related]
13. Primary sclerosing cholangitis: diagnostic performance of MRI compared to blood tests and clinical scoring systems for the evaluation of histopathological severity of disease.
Song C; Lewis S; Kamath A; Hectors S; Putra J; Kihira S; Bane O; Ahmad J; Babb J; Thung S; Taouli B
Abdom Radiol (NY); 2020 Feb; 45(2):354-364. PubMed ID: 31844914
[TBL] [Abstract][Full Text] [Related]
14. Validation of the prognostic value of histologic scoring systems in primary sclerosing cholangitis: An international cohort study.
de Vries EM; de Krijger M; Färkkilä M; Arola J; Schirmacher P; Gotthardt D; Goeppert B; Trivedi PJ; Hirschfield GM; Ytting H; Vainer B; Buuren HR; Biermann K; Harms MH; Chazouilleres O; Wendum D; Kemgang AD; Chapman RW; Wang LM; Williamson KD; Gouw AS; Paradis V; Sempoux C; Beuers U; Hübscher SG; Verheij J; Ponsioen CY
Hepatology; 2017 Mar; 65(3):907-919. PubMed ID: 27880989
[TBL] [Abstract][Full Text] [Related]
15. Comparison of liver stiffness measurement with MRE and liver and spleen volumetry for prediction of disease severity and hepatic decompensation in patients with primary sclerosing cholangitis.
Idilman IS; Low HM; Bakhshi Z; Eaton J; Venkatesh SK
Abdom Radiol (NY); 2020 Mar; 45(3):701-709. PubMed ID: 31894383
[TBL] [Abstract][Full Text] [Related]
16. Reporting standards for primary sclerosing cholangitis using MRI and MR cholangiopancreatography: guidelines from MR Working Group of the International Primary Sclerosing Cholangitis Study Group.
Venkatesh SK; Welle CL; Miller FH; Jhaveri K; Ringe KI; Eaton JE; Bungay H; Arrivé L; Ba-Ssalamah A; Grigoriadis A; Schramm C; Fulcher AS;
Eur Radiol; 2022 Feb; 32(2):923-937. PubMed ID: 34363134
[TBL] [Abstract][Full Text] [Related]
17. Systematic review: non-invasive prognostic tests for primary sclerosing cholangitis.
Mazhar A; Russo MW
Aliment Pharmacol Ther; 2021 Apr; 53(7):774-783. PubMed ID: 33608929
[TBL] [Abstract][Full Text] [Related]
18. The role of imaging in determining prognosis for primary sclerosing cholangitis: A systematic review.
Segal D; Marotta P; Mosli M; Zou G; Feagan BG; Al-Judaibi B
Saudi J Gastroenterol; 2019; 25(3):152-158. PubMed ID: 31044745
[TBL] [Abstract][Full Text] [Related]
19. Risk stratification in primary sclerosing cholangitis: comparison of biliary stricture severity on MRCP versus liver stiffness by MR elastography and vibration-controlled transient elastography.
Tafur M; Cheung A; Menezes RJ; Feld J; Janssen H; Hirschfield GM; Jhaveri KS
Eur Radiol; 2020 Jul; 30(7):3735-3747. PubMed ID: 32130494
[TBL] [Abstract][Full Text] [Related]
20. Adult Primary Sclerosing Cholangitis (PSC) subjects have worse biliary disease at diagnosis compared to pediatric PSC subjects.
Kulkarni S; Bhimaniya S; Chi L; Tica S; Alghamdi S; Stoll J; Caudill K; Fleckenstein J
Clin Imaging; 2023 May; 97():7-13. PubMed ID: 36868034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
